Matches in Wikidata for { <http://www.wikidata.org/entity/Q92564069> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q92564069 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92564069 description "scientific article published on 04 June 2019" @default.
- Q92564069 description "wetenschappelijk artikel" @default.
- Q92564069 description "наукова стаття, опублікована 4 червня 2019" @default.
- Q92564069 name "3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo" @default.
- Q92564069 name "3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo" @default.
- Q92564069 type Item @default.
- Q92564069 label "3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo" @default.
- Q92564069 label "3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo" @default.
- Q92564069 prefLabel "3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo" @default.
- Q92564069 prefLabel "3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo" @default.
- Q92564069 P1433 Q92564069-A2BE9136-B263-4DC3-A20B-A37276EA0BAC @default.
- Q92564069 P1476 Q92564069-7760DBFE-3804-4FBA-B0E7-385F8558DC66 @default.
- Q92564069 P304 Q92564069-9F1E23DB-70D8-400A-9709-251EFA71E6CC @default.
- Q92564069 P31 Q92564069-BBCD4847-E4BB-43B1-A14C-D91996B7018C @default.
- Q92564069 P356 Q92564069-3CAC7DB6-57B4-4048-81E1-0ECEC1F51D10 @default.
- Q92564069 P478 Q92564069-07EBC4F5-2FA9-42B1-8B3A-EAD94F7D02CA @default.
- Q92564069 P50 Q92564069-053192E5-76E5-4C7F-AAFA-AFC1D70A7C4A @default.
- Q92564069 P50 Q92564069-4840CB1E-D58E-4410-887B-02D45FE88DB4 @default.
- Q92564069 P50 Q92564069-6CAF1286-A5EB-4DDD-9A1B-6B664A387589 @default.
- Q92564069 P50 Q92564069-9B3845C8-0AF4-4340-8663-C4BF5DA8D073 @default.
- Q92564069 P50 Q92564069-CAFEC827-4D4B-4093-8120-F59C341184D2 @default.
- Q92564069 P577 Q92564069-779CFEE1-03E4-40C1-862F-C3CC1B1384F8 @default.
- Q92564069 P698 Q92564069-4669ACEB-694F-4141-A4ED-5765C050582E @default.
- Q92564069 P921 Q92564069-31C3A413-D8DE-4A3B-B0CC-2D8BD2662D13 @default.
- Q92564069 P921 Q92564069-74D53663-34C0-4CDD-A08B-26D344CC4847 @default.
- Q92564069 P356 J.LFS.2019.06.005 @default.
- Q92564069 P698 31170419 @default.
- Q92564069 P1433 Q5256275 @default.
- Q92564069 P1476 "3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo" @default.
- Q92564069 P304 "116530" @default.
- Q92564069 P31 Q13442814 @default.
- Q92564069 P356 "10.1016/J.LFS.2019.06.005" @default.
- Q92564069 P478 "231" @default.
- Q92564069 P50 Q55404859 @default.
- Q92564069 P50 Q57559883 @default.
- Q92564069 P50 Q59818418 @default.
- Q92564069 P50 Q90192532 @default.
- Q92564069 P50 Q91953110 @default.
- Q92564069 P577 "2019-06-04T00:00:00Z" @default.
- Q92564069 P698 "31170419" @default.
- Q92564069 P921 Q18555025 @default.
- Q92564069 P921 Q18936 @default.